Skip to main content

Day: May 31, 2023

AUGA group, AB interim financial results for the 3-month period ended 31 March 2023

In the first quarter of 2023, the sales revenue of AUGA group, AB and its subsidiaries (hereinafter – the Group) increased by 24% to EUR 21.70 million due to the stable production activity and the increase in production prices in 2022, compared to EUR 17.56 million in the same period last year. Due to uncertainty in the crop growing and dairy segments caused by volatile production prices, the Group significantly lowered its forecast prices for the 2023 harvest, resulting a lower result for the first quarter, compared to the previous year. The gross profit of EUR 2.45 million compares to a profit of EUR 5.65 million for the same period last year. The Group’s EBITDA decreased by 58% to EUR 2.79 million compared to EUR 6.71 million in the first quarter of previous year. “Agricultural activity is constantly changing and depends...

Continue reading

Treasury Bond Auction Announcement – RIKB 26 1015 – RIKS 37 0115

Series RIKB 26 1015 RIKS 37 0115ISIN IS0000034874 IS0000033793Maturity Date 10/15/2026 01/15/2037Auction Date 06/02/2023 06/02/2023Settlement Date 06/07/2023 06/07/202310% addition 06/06/2023 06/06/2023On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bonds in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bonds must be received by the Central Bank before 14:00 on the Settlement Date, and the Bonds will be delivered in electronic form on the same day. Article 6 of the General Terms of Auction for Treasury bonds applies for the right to purchase an additional 10%. Further reference is made to the description of the Treasury bond and the General Terms of Auction for Treasury bonds on the Government...

Continue reading

Update — Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference

IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company’s management team will participate at the Jefferies Healthcare Conference. Jefferies Healthcare ConferenceDate: Wednesday, June 7, 2023Location: Marriott Marquis, New York, NYPresentation: 11:00 a.m. EDT (webcast) Links to the webcast and presentation will be posted on the Investors section of the Reneo Pharmaceuticals corporate website. About Reneo PharmaceuticalsReneo is a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated...

Continue reading

WISeKey Launches WISeAI.IO 2.0 to Effectively Monitor Cybersecurity Threats on Root of Trust for Individuals and Objects Using AI Advanced Algorithms

WISeKey Launches WISeAI.IO 2.0 to Effectively Monitor Cybersecurity Threats on Root of Trust for Individuals and Objects Using AI Advanced Algorithms www.wiseai.io detects and responds to attacks on RoTs Geneva and Zug Switzerland – May 31, 2023 – WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY), a leading cybersecurity, IoT and AI company, announced the launch of WISeAI.IO 2.0 machine-learning tool, which is specifically designed to monitor the behavior and activities within a PKI system and identify any abnormal patterns or activities. By analyzing large volumes of data related to certificate issuance, revocation, and usage, WISeAI algorithms can learn the normal behavior and establish a baseline. Any deviations from this baseline can be flagged as potential security threats, such as unauthorized certificate issuance...

Continue reading

Canadian North Resources Inc. Announces Financial Results for the First Quarter Ended March 31, 2023

Figure 1 Drilling targets within the 96.9km2 mining leases of the Ferguson Lake ProjectFigure 2 Five new targets identified in the exploration claims (156.9km2) outside the mining leases (96.9km2) of the Ferguson Lake ProjectTORONTO, May 31, 2023 (GLOBE NEWSWIRE) — Canadian North Resources Inc. (“the Company”, TSXV: CNRI; OTCQX: CNRSF; FSE: EO0 (E-O-zero)) is pleased to report the financial results for the first quarter ended March 31, 2023. “Based on the results of the 18,144 meter drilling completed in 2022, we have commenced a new 20,000-meter drilling program at our 100% owned Ferguson Lake nickel, copper, cobalt, palladium and platinum project (“the Ferguson Lake Project”) during the past quarter,” said Dr. Kaihui Yang, the President & CEO of the Company. “We continue to expand the mineral resources from the current...

Continue reading

LPL Financial Welcomes Return of Individual Financial Services

CHARLOTTE, N.C., May 31, 2023 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Neil Pettes, CFP® and the team at Individual Financial Services have returned to LPL Financial’s broker-dealer, RIA and custodial platforms. He reported having served approximately $400 million in advisory, brokerage and retirement plan assets*, and joins LPL from Cambridge Investment Research, Inc. Located north of Pittsburgh in Wexford, Pa., Individual Financial Services launched in 1971 by Founding Partner Martin Mancuso with a focus on providing superior client service, approaching each relationship with integrity, trust and commitment. He understood that each client has unique financial needs, which has been a guiding principle for the firm over the past four decades. Pettes joined the practice in 1994, starting as the...

Continue reading

NFI Announces Increase of Previously Announced Bought Deal Public Offering of Subscription Receipts to C$108 Million

NFI also provides Supplemental Information relating to its Special Meeting of Shareholders NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES WINNIPEG, Manitoba, May 31, 2023 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that, due to strong demand, the Company has increased the size of the previously announced “bought deal” public offering of subscription receipts to 13,133,000 subscription receipts (the “Subscription Receipts”) at a price of C$8.25 per Subscription Receipt, for aggregate gross proceeds of approximately C$108 million (approximately US$80 million) (the “Offering”). The Offering is being made through a syndicate...

Continue reading

Hovnanian Enterprises Reports Fiscal 2023 Second Quarter Results

Achieved Income Before Income Taxes of $46 MillionExceeded High End of Guidance for Adjusted Pretax Income by 32%Net Contracts per Community Increased 100% versus First Quarter 2023Consolidated Community Count Increased 12% Year over YearRedeemed in May $100 Million of Principal Amount of 7.75% Senior Secured Notes Due February 2026 MATAWAN, N.J., May 31, 2023 (GLOBE NEWSWIRE) — Hovnanian Enterprises, Inc. (NYSE: HOV), a leading national homebuilder, reported results for its fiscal second quarter and six months ended April 30, 2023. RESULTS FOR THE THREE-MONTH AND SIX-MONTH PERIODS ENDED APRIL 30, 2023:Total revenues were $703.7 million in the second quarter of fiscal 2023, compared with $702.5 million in the same quarter of the prior year. For the six months ended April 30, 2023, total revenues were $1.22 billion compared with...

Continue reading

Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients through development of novel DNA-damage response inhibitor therapeutics, announced financial results for the quarter ended March 31, 2023, and provided a corporate update. Corporate highlights during the past quarter included:Presentation of pre-clinical data at the annual meeting of the American Association of Cancer Research (AACR) demonstrating the potential of the Company’s lead kt-3000 dual function DNA-damage response inhibitors as a potential treatment for Ewing sarcoma, a rare childhood tumor; Receipt of non-dilutive funding from the National Research Council of Canada Industrial Research Assistance Program; and An address by...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.